Site Readiness Under ICH E6(R3)

Key expectations for site readiness under ICH E6(R3), including documentation, risk-based oversight, and digital data governance.

Site Readiness Under ICH E6(R3)

Key expectations for site readiness under ICH E6(R3), including documentation, risk-based oversight, and digital data governance.

Site Readiness Under ICH E6(R3): Collaborative Accountability

ICH E6(R3) strengthens the shared responsibility between sponsors and sites. Where E6(R2) left room for interpretation, ICH E6(R3) provides clearer expectations for:

Qualified, documented personnel
Transparent task delegation
Data integrity through digital traceability
Shared monitoring responsibilities

What Changes in Practice?

Area

Expectation

Practical Adjustment

Training & Role Qualification

Training and delegation must be documented

Keep a real-time delegation log and training binder (digital preferred)

Data Governance

Traceable, auditable records are required

Ensure systems have audit trails and version control

Monitoring Collaboration

Oversight is shared

Participate actively in central monitoring reviews

IP & Digital Tools

Electronic processes must be validated

Confirm validation with sponsor or vendor, especially for eConsent or eSource

Bottom Line

Sites are not expected to do more, but to show clarity, traceability, and readiness. The focus shifts from completing tasks to demonstrating control.

Site Readiness Checklist Infographic

The MyRBQM® Portal allows sponsors to align site engagement, monitoring signals, and issue handling — improving readiness without adding burden.

Stay Informed with Us

Explainable AI in Clinical Trials

Clinical trial AI should do more than detect patterns. It must help teams understand, challenge, and document the rationale behind risk signals. Cyntegrity’s latest research reference explores how explainable mathematical discovery can support the next generation of RBQM innovation....

16 July 2026
9:14 AM

RBQM Explained: Why 100% SDV Falls Short in Clinical Trials

An educational excerpt from MyRBQM Essentials White Belt explaining why traditional monitoring and 100% Source Data Verification are no longer enough for modern clinical trial oversight....

6 July 2026
2:05 PM

Media Inquiries

Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.

Site Readiness Under ICH E6(R3)

Site Readiness Under ICH E6(R3)

Site Readiness Under ICH E6(R3): Collaborative Accountability

What Changes in Practice?

Area

Expectation

Practical Adjustment

Training & Role Qualification

Training and delegation must be documented

Keep a real-time delegation log and training binder (digital preferred)

Data Governance

Traceable, auditable records are required

Ensure systems have audit trails and version control

Monitoring Collaboration

Oversight is shared

Participate actively in central monitoring reviews

IP & Digital Tools

Electronic processes must be validated

Confirm validation with sponsor or vendor, especially for eConsent or eSource

Bottom Line

Site Readiness Checklist Infographic

Stay Informed with Us

Explainable AI in Clinical Trials

RBQM Explained: Why 100% SDV Falls Short in Clinical Trials

Media Inquiries

Site Readiness E6(R3)

Site Readiness E6(R3)

+49 (0) 6192 470 113.50 (Europe)

+1 (0) 888 812 RBQM (USA)

Site Readiness Under ICH E6(R3)

Site Readiness Under ICH E6(R3)

Site Readiness Under ICH E6(R3): Collaborative Accountability

What Changes in Practice?

Area

Expectation

Practical Adjustment

Training & Role Qualification

Training and delegation must be documented

Keep a real-time delegation log and training binder (digital preferred)

Data Governance

Traceable, auditable records are required

Ensure systems have audit trails and version control

Monitoring Collaboration

Oversight is shared

Participate actively in central monitoring reviews

IP & Digital Tools

Electronic processes must be validated

Confirm validation with sponsor or vendor, especially for eConsent or eSource

Bottom Line

Site Readiness Checklist Infographic

Stay Informed with Us

Explainable AI in Clinical Trials

RBQM Explained: Why 100% SDV Falls Short in Clinical Trials

Media Inquiries

Site Readiness E6(R3)

Site Readiness E6(R3)

+49 (0) 6192 470 113.50 (Europe)

+1 (0) 888 812 RBQM (USA)

What Is the Financial Value of RBQM?

Download the updated case study with 2026 Tufts CSDD insights and Cyntegrity’s operational value perspective.

Download the updated case study with 2026 Tufts CSDD insights
and Cyntegrity’s operational value perspective.